CXCL10 and Sepsis: Further analysis demonstrated that SFT2D1 inhibition significantly decreased the expression levels of key inflammatory cytokines CXCL10 and IL-6 (P < 0.05) (Figure 10E), suggesting a role for SFT2D1 in promoting the inflammatory response in sepsis.